DJE Kapital AG Acquires 726,652 Shares of Amrize Ltd $AMRZ

DJE Kapital AG boosted its holdings in shares of Amrize Ltd (NYSE:AMRZ) by 2,005.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 762,887 shares of the company’s stock after purchasing an additional 726,652 shares during the quarter. Amrize comprises approximately 1.2% of DJE Kapital AG’s holdings, making the stock its 26th largest position. DJE Kapital AG owned about 0.14% of Amrize worth $41,986,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. MCF Advisors LLC bought a new stake in Amrize during the 4th quarter valued at approximately $27,000. State of Wyoming bought a new stake in shares of Amrize in the 3rd quarter worth approximately $32,000. Basepoint Wealth LLC bought a new stake in shares of Amrize in the 4th quarter worth approximately $33,000. Laurel Wealth Advisors LLC bought a new stake in shares of Amrize in the 4th quarter worth approximately $34,000. Finally, US Bancorp DE bought a new stake in shares of Amrize in the 3rd quarter worth approximately $38,000.

Insider Buying and Selling

In related news, insider Mario Gross bought 2,800 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was acquired at an average cost of $49.17 per share, with a total value of $137,676.00. Following the acquisition, the insider owned 33,747 shares in the company, valued at approximately $1,659,339.99. This represents a 9.05% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Jan Philipp Jenisch bought 21,417 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was bought at an average cost of $49.67 per share, with a total value of $1,063,782.39. Following the completion of the acquisition, the chief executive officer owned 1,724,999 shares in the company, valued at $85,680,700.33. This represents a 1.26% increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders acquired 54,920 shares of company stock valued at $2,717,429. 0.54% of the stock is currently owned by corporate insiders.

Amrize Price Performance

Shares of AMRZ stock opened at $52.32 on Friday. The stock has a 50 day moving average of $54.12 and a two-hundred day moving average of $55.48. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $65.94. The company has a market capitalization of $28.94 billion and a P/E ratio of 25.03.

Amrize (NYSE:AMRZ) last issued its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a return on equity of 9.84% and a net margin of 9.70%.The company had revenue of $2.18 billion during the quarter. The firm’s revenue was up 4.7% compared to the same quarter last year. As a group, equities analysts expect that Amrize Ltd will post 2.76 EPS for the current year.

Amrize Cuts Dividend

The business also recently announced a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were issued a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio is presently 21.05%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Stephens reiterated an “overweight” rating and issued a $65.00 price objective on shares of Amrize in a research report on Monday, May 18th. Citigroup reduced their price objective on Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Wall Street Zen upgraded Amrize from a “sell” rating to a “hold” rating in a research report on Sunday, March 1st. Oppenheimer set a $68.00 price objective on Amrize in a research report on Friday, May 1st. Finally, Royal Bank Of Canada reduced their price objective on Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Amrize has a consensus rating of “Moderate Buy” and a consensus price target of $64.86.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.